How do HAEMONETICS CORP and Metallus Inc. compare by revenue?

HAEMONETICS CORP reported revenue of $346.4M in Q4 FY2026, while Metallus Inc. reported $308.3M in Q1 FY2026. HAEMONETICS CORP is 1.1× larger by last-quarter revenue.

Which is growing revenue faster, HAEMONETICS CORP or Metallus Inc.?

HAEMONETICS CORP's latest revenue grew 4.8% year-over-year, versus 9.9% for Metallus Inc.. Metallus Inc. is growing faster on a YoY basis.

Which has a higher gross margin, HAEMONETICS CORP or Metallus Inc.?

HAEMONETICS CORP's gross margin is 57.2% vs Metallus Inc.'s 8.1%. HAEMONETICS CORP converts more of each revenue dollar into gross profit.

Which has a higher net margin, HAEMONETICS CORP or Metallus Inc.?

HAEMONETICS CORP's net margin is 28.1% vs Metallus Inc.'s 1.8%. HAEMONETICS CORP has the higher bottom-line margin.

What is the 2-year revenue CAGR for HAEMONETICS CORP vs Metallus Inc.?

Over the trailing 8 quarters, HAEMONETICS CORP compounded revenue at roughly 1.5% per year, versus 2.3% for Metallus Inc.. Metallus Inc. has the faster medium-term growth trajectory.

Where does this HAE vs MTUS data come from?

All figures are parsed directly from SEC EDGAR 10-Q / 10-K / 20-F / 6-K filings (for US-listed issuers) or EDINET filings (for Japanese issuers), then normalised into a common schema. Numbers update automatically as new filings are released.

vs

Side-by-side financial comparison of HAEMONETICS CORP (HAE) and Metallus Inc. (MTUS). Click either name above to swap in a different company.

HAEMONETICS CORP is the larger business by last-quarter revenue ($346.4M vs $308.3M, roughly 1.1× Metallus Inc.). HAEMONETICS CORP runs the higher net margin — 28.1% vs 1.8%, a 26.3% gap on every dollar of revenue. On growth, Metallus Inc. posted the faster year-over-year revenue change (9.9% vs 4.8%). Over the past eight quarters, Metallus Inc.'s revenue compounded faster (2.3% CAGR vs 1.5%).

HAEMONETICS CORPHAEEarnings & Financial Report

NYSE · Health Care · Surgical & Medical Instruments & Apparatus

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

Metallus Inc.MTUSEarnings & Financial Report

NYSE · Materials · Steel Works, Blast Furnaces & Rolling Mills (Coke Ovens)

HAE vs MTUS — Head-to-Head

Bigger by revenue

HAE

1.1× larger

$346.4M

$308.3M

Growing faster (revenue YoY)

MTUS

+5.1% gap

9.9%

4.8%

Higher net margin

HAE

26.3% more per $

28.1%

1.8%

Faster 2-yr revenue CAGR

MTUS

Annualised

2.3%

1.5%

Income Statement — Q4 FY2026 vs Q1 FY2026

Metric	HAE	MTUS
Revenue	$346.4M	$308.3M
Net Profit	$97.3M	$5.4M
Gross Margin	57.2%	8.1%
Operating Margin	36.1%	—
Net Margin	28.1%	1.8%
Revenue YoY	4.8%	9.9%
Net Profit YoY	—	315.4%
EPS (diluted)	—	$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue

HAE

MTUS

Q1 26	$346.4M	$308.3M
Q4 25	$339.0M	$267.3M
Q3 25	$327.3M	$305.9M
Q2 25	$321.4M	$304.6M
Q1 25	$330.6M	$280.5M
Q4 24	$348.5M	$240.5M
Q3 24	$345.5M	$227.2M
Q2 24	$336.2M	$294.7M

Net Profit

HAE

MTUS

Q1 26	$97.3M	$5.4M
Q4 25	$44.7M	$-14.3M
Q3 25	$38.7M	$8.1M
Q2 25	$34.0M	$3.7M
Q1 25	$58.0M	$1.3M
Q4 24	$37.5M	$-21.4M
Q3 24	$33.8M	$-5.9M
Q2 24	$38.4M	$4.6M

Gross Margin

HAE

MTUS

Q1 26	57.2%	8.1%
Q4 25	59.7%	2.2%
Q3 25	59.5%	11.4%
Q2 25	59.8%	10.6%
Q1 25	58.4%	7.8%
Q4 24	55.5%	4.5%
Q3 24	54.2%	5.3%
Q2 24	52.0%	8.2%

Operating Margin

HAE

MTUS

Q1 26	36.1%	—
Q4 25	19.9%	-7.7%
Q3 25	17.9%	3.6%
Q2 25	16.8%	2.8%
Q1 25	21.6%	1.0%
Q4 24	16.9%	-10.1%
Q3 24	15.0%	-3.1%
Q2 24	11.8%	2.1%

Net Margin

HAE

MTUS

Q1 26	28.1%	1.8%
Q4 25	13.2%	-5.3%
Q3 25	11.8%	2.6%
Q2 25	10.6%	1.2%
Q1 25	17.5%	0.5%
Q4 24	10.8%	-8.9%
Q3 24	9.8%	-2.6%
Q2 24	11.4%	1.6%

EPS (diluted)

HAE

MTUS

Q1 26	—	$0.13
Q4 25	$0.95	$-0.34
Q3 25	$0.81	$0.19
Q2 25	$0.70	$0.09
Q1 25	$1.17	$0.03
Q4 24	$0.74	$-0.46
Q3 24	$0.66	$-0.13
Q2 24	$0.74	$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric	HAE	MTUS
Cash + ST InvestmentsLiquidity on hand	$245.4M	$104.0M
Total DebtLower is stronger	$1.2B	—
Stockholders' EquityBook value	$796.3M	$683.0M
Total Assets	$2.4B	$1.1B
Debt / EquityLower = less leverage	1.53×	—

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments

HAE

MTUS

Q1 26	$245.4M	$104.0M
Q4 25	$363.4M	$156.7M
Q3 25	$296.4M	$191.5M
Q2 25	$292.9M	$190.8M
Q1 25	$306.8M	$180.3M
Q4 24	$320.8M	$240.7M
Q3 24	$299.3M	$254.6M
Q2 24	$344.4M	$272.8M

Total Debt

HAE

MTUS

Q1 26	$1.2B	—
Q4 25	$1.2B	—
Q3 25	$1.2B	$0
Q2 25	$1.2B	$0
Q1 25	$1.2B	$5.4M
Q4 24	—	$5.4M
Q3 24	—	$13.2M
Q2 24	—	$13.2M

Stockholders' Equity

HAE

MTUS

Q1 26	$796.3M	$683.0M
Q4 25	$911.5M	$686.0M
Q3 25	$849.2M	$697.7M
Q2 25	$882.3M	$690.0M
Q1 25	$820.8M	$686.1M
Q4 24	$906.9M	$690.5M
Q3 24	$878.9M	$712.7M
Q2 24	$905.4M	$736.3M

Total Assets

HAE

MTUS

Q1 26	$2.4B	$1.1B
Q4 25	$2.5B	$1.1B
Q3 25	$2.4B	$1.2B
Q2 25	$2.5B	$1.1B
Q1 25	$2.5B	$1.1B
Q4 24	$2.5B	$1.1B
Q3 24	$2.5B	$1.1B
Q2 24	$2.5B	$1.1B

Debt / Equity

HAE

MTUS

Q1 26	1.53×	—
Q4 25	1.34×	—
Q3 25	1.44×	0.00×
Q2 25	1.39×	0.00×
Q1 25	1.49×	0.01×
Q4 24	—	0.01×
Q3 24	—	0.02×
Q2 24	—	0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric	HAE	MTUS
Operating Cash FlowLast quarter	$293.2M	—
Free Cash FlowOCF − Capex	$209.9M	—
FCF MarginFCF / Revenue	60.6%	—
Capex IntensityCapex / Revenue	9.5%	0.0%
Cash ConversionOCF / Net Profit	3.01×	—
TTM Free Cash FlowTrailing 4 quarters	$417.1M	—